Ketogenic or very-low-carbohydrate diets can be a practical approach to weight loss and glycemic control for some people, while others find long-term adherence difficult [[284], [285], [286]]
Clinical trials of GLP-1 medications, including the STEP program for semaglutide and SURMOUNT trials for tirzepatide, have documented improvements in physical function scores and quality of life measures
Discussion and Review of Recent Literature In the case of our patient, it appears that she developed IIH due to the abrupt cessation of the GLP-1 receptor agonist prescribed to her with resultant rapid weight gain, with her BMI increasing from 29 to 34 in a little over a month
The defense will show you impressive preclinical data
[9] [11] The neurobiological mechanisms by which GLP-1 receptor agonists might influence alcohol consumption involve complex interactions within brain reward circuitry
Heres how to minimize discomfort while your body adjusts